Skip to main content

PE-22-28 vs Semaglutide

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

PE-22-28

PE-22-28 is a synthetic peptide fragment derived from research on the SAMP8 mouse model of accelerated aging. It has shown potential for enhancing memory and reducing cognitive decline.

Full details →

Semaglutide

Semaglutide is a GLP-1 receptor agonist that has revolutionized weight management and diabetes treatment. FDA-approved as Ozempic (diabetes), Wegovy (weight loss), and Rybelsus (oral form), it has become one of the most prescribed peptides worldwide.

Full details →

Side-by-Side Comparison

AspectPE-22-28Semaglutide
MechanismDerived from the protein that is deficient in SAMP8 mice. May work by inhibiting protein phosphatase 2A methylesterase, thereby affecting memory-related signaling pathways.Mimics glucagon-like peptide-1 (GLP-1) to stimulate insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite through hypothalamic signaling. The result is significant reduction in food intake and improved glycemic control.
Typical DosageResearch protocols vary. Intranasal dosing has been studied at various concentrations. Optimal human dosing not established.Wegovy (weight loss): Start at 0.25mg weekly, titrate up to 2.4mg weekly over 16-20 weeks. Ozempic (diabetes): 0.25mg to 1mg weekly. Research protocols vary.
AdministrationIntranasal administration preferred for CNS delivery. Research compound with limited human use data.Subcutaneous injection once weekly, typically in abdomen, thigh, or upper arm. Rybelsus is taken orally on empty stomach. Dose titration is essential to minimize GI side effects.
Side EffectsVery limited human data. Primarily studied in animal models for safety and efficacy.Common: nausea, vomiting, diarrhea, constipation, abdominal pain. These typically decrease over time. May cause injection site reactions.
Best For

Key Differences

Unique to PE-22-28:

Unique to Semaglutide:

Detailed Analysis

PE-22-28 and Semaglutide are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose PE-22-28 for Cognitive Performance, Anti-Aging & Longevity. Choose Semaglutide for Fat Loss, Gut Health.

Ready to Learn More?